Literature DB >> 10393344

Thimet oligopeptidase cleaves the full-length Alzheimer amyloid precursor protein at a beta-secretase cleavage site in COS cells.

H Koike1, H Seki, Z Kouchi, M Ito, T Kinouchi, S Tomioka, H Sorimachi, T C Saido, K Maruyama, K Suzuki, S Ishiura.   

Abstract

We developed an assay method using a novel quenched fluorescent substrate (QFS) flanking the beta-cleavage site of amyloid precursor protein (APP), and purified a candidate beta-secretase from bovine brain. N-terminal amino acid analysis showed the candidate to be thimet oligopeptidase (TOP). The cDNA for human TOP was cloned from a human brain cDNA library and expressed in COS cells. The enzyme was further purified on a Ni2+-agarose column. TOP cleaved the Swedish Alzheimer's substrate (SEVNLDAEFR) as well as the normal substrate (SEVKMDAEFR). We then coexpressed TOP with APP695 in COS cells, collected transfected cells and conditioned media, and analyzed them by immunoblotting. The antibody against the specific secreted APP cleaved by beta-secretase (sAPPbeta) detected the secretion of sAPPbeta only from APP/hTOP-overexpressing cells, and not from cells overexpressing of antisense hTOP cDNA. Finally, we analyzed the immunolocalization of overexpressed hTOP in COS cells. Most hTOP was localized in the nuclei, but a small amount was localized in the Golgi or other organelles around the nuclei. These results suggest that TOP has a beta-secretase-like activity responsible for the processing of APP.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10393344     DOI: 10.1093/oxfordjournals.jbchem.a022428

Source DB:  PubMed          Journal:  J Biochem        ISSN: 0021-924X            Impact factor:   3.387


  9 in total

1.  Metabolism of amyloid precursor protein in COS cells transfected with a beta-secretase candidate.

Authors:  H Koike; Z Kouchi; T Kinouchi; T Maeda; H Sorimachi; T C Saido; K Maruyama; A Okuyama; K Suzuki; S Ishiura
Journal:  Cytotechnology       Date:  2000-07       Impact factor: 2.058

2.  Phenserine regulates translation of beta -amyloid precursor protein mRNA by a putative interleukin-1 responsive element, a target for drug development.

Authors:  K T Shaw; T Utsuki; J Rogers; Q S Yu; K Sambamurti; A Brossi; Y W Ge; D K Lahiri; N H Greig
Journal:  Proc Natl Acad Sci U S A       Date:  2001-06-12       Impact factor: 11.205

3.  Flexibility in substrate recognition by thimet oligopeptidase as revealed by denaturation studies.

Authors:  Jeffrey A Sigman; Tasneem H Patwa; Ana V Tablante; Calleen D Joseph; Marc J Glucksman; Adele J Wolfson
Journal:  Biochem J       Date:  2005-05-15       Impact factor: 3.857

4.  Regulation of cell-surface major histocompatibility complex class I expression by the endopeptidase EC3.4.24.15 (thimet oligopeptidase).

Authors:  Sandra I Kim; Amanda Pabon; Todd A Swanson; Marc J Glucksman
Journal:  Biochem J       Date:  2003-10-01       Impact factor: 3.857

5.  The Enigma of Tripeptidyl-Peptidase II: Dual Roles in Housekeeping and Stress.

Authors:  Giulio Preta; Rainier de Klark; Riccardo Gavioli; Rickard Glas
Journal:  J Oncol       Date:  2010-08-18       Impact factor: 4.375

Review 6.  The Toxicity and Polymorphism of β-Amyloid Oligomers.

Authors:  Ya-Ru Huang; Rui-Tian Liu
Journal:  Int J Mol Sci       Date:  2020-06-24       Impact factor: 5.923

7.  Mucin-Type O-Glycosylation Proximal to β-Secretase Cleavage Site Affects APP Processing and Aggregation Fate.

Authors:  YashoNandini Singh; Deepika Regmi; David Ormaza; Ramya Ayyalasomayajula; Nancy Vela; Gustavo Mundim; Deguo Du; Dmitriy Minond; Maré Cudic
Journal:  Front Chem       Date:  2022-04-08       Impact factor: 5.545

Review 8.  Advances with RNA interference in Alzheimer's disease research.

Authors:  Shun Chen; Xuemei Ge; Yinghui Chen; Nan Lv; Zhenguo Liu; Weien Yuan
Journal:  Drug Des Devel Ther       Date:  2013-02-22       Impact factor: 4.162

9.  Tyrosine O-GalNAc Alters the Conformation and Proteolytic Susceptibility of APP Model Glycopeptides.

Authors:  YashoNandini Singh; David Ormaza; Alessandra Massetti; Dmitriy Minond; Maré Cudic
Journal:  ACS Chem Neurosci       Date:  2021-07-29       Impact factor: 5.780

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.